POINT 1 Study
by Parallel 6, Inc.
Version 0.2.8
📅 Updated 2017-09-28
Features POINT 1 Study
"Please Note: This app is only for use by those participating in this study.
The POINT 1 Study is a two part pediatric study of Afrezza inhaled human insulin in pediatric patients with type 1 diabetes mellitus.
The POINT 1 Study App is a tool for for enrolled patients to manage and understand study participation."
Secure & Private
Your data is protected with industry-leading security protocols.
24/7 Support
Our dedicated support team is always ready to help you.
Personalization
Customize the app to match your preferences and workflow.
See the POINT 1 Study in Action
Get the App Today
Available for Android 8.0 and above